Biblio Discovery — Demo Discovery Service

5 hasil untuk "Yan-Liang Lin"

Menampilkan 1–5 · 1,78 detik · RSS

  1. Artikel Jurnal

    A novel endogenous CD16-Expressing Natural Killer Cell for cancer immunotherapy

    Zih-Fei Cheng; Hao-Kang Li; Hsiu-Ping Yang dkk.

    Biochemistry and Biophysics Reports, Vol. 26 · 2021 · Inggris · DOAJ Scopus

    Natural killer (NK) cells, as a potential source for off-the-shelf cell therapy, attack tumor cells with low risk of severe cytokine release syndrome (CRS) or graft-versus-host disease (GvHD). Fcγ receptor IIIA, also known as CD16, further confers NK cells with antibody-dependent cell-mediated…

  2. Artikel Jurnal Teks lengkap

    MicroRNA-Like Small RNAs Prediction in the Development of Antrodia cinnamomea

    Yan-Liang Lin; Li-Ting Ma; Yi-Ru Lee dkk.

    PLOS ONE, Vol. 10 No. 4 · 2015 · Inggris · PLOS Scopus

    Antrodia cinnamomea, a precious, host-specific brown-rot fungus that has been used as a folk medicine in Taiwan for centuries is known to have diverse bioactive compounds with potent pharmaceutical activity. In this study, different fermentation states of A. cinnamomea (wild-type fruiting bodies…

    Juga tersedia di: DOAJ

  3. Artikel Jurnal

    Synthesis of Novel Suramin Analogs With Anti-Proliferative Activity via FGF1 and FGFRD2 Blockade

    Nuzhat Parveen; Yan-Liang Lin; Ruey-Hwang Chou dkk.

    Frontiers in Chemistry, Vol. 9 · 2022 · Inggris · DOAJ Scopus

    A promising approach in cancer therapy is the inhibition of cell proliferation using small molecules. In this study, we report the synthesis of suramin derivatives and their applications. We used NMR spectroscopy and docking simulations to confirm binding sites and three-dimensional models of the…

  4. Artikel Jurnal

    Allogeneic cetuximab-armed gamma delta T cells using antibody-cell conjugation technology for the treatment of EGFR-expressing solid tumors

    Yi-Chiu Kuo; Hao-Kang Li; Tai-Sheng Wu dkk.

    Journal for ImmunoTherapy of Cancer, Vol. 13 No. 7 · 2025 · Inggris · DOAJ Scopus

    Background Targeting epidermal growth factor receptor (EGFR) has become a strategic approach in cancer therapy, using various modalities including chimeric antigen receptor (CAR)-αβT cell therapies. Despite significant advancements in autologous CAR-αβT cell therapies in B-cell lymphoma, current…